How to buy Quotient stock | $4.16

Quotient Limited is a diagnostics & research business based in the US. Quotient shares (QTNT) are listed on the NASDAQ and all prices are listed in US Dollars. Quotient employs 435 staff and has a trailing 12-month revenue of around 0.00.

Quotient stock price (NASDAQ: QTNT)

Use our graph to track the performance of QTNT stocks over time.

Quotient shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$4.16
52-week range	$2.99 - $8.00
50-day moving average	$3.73
200-day moving average	$4.28
Wall St. target price	$10.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.73

Buy Quotient shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Quotient stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Quotient Limited by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Quotient price performance over time

Historical closes compared with the close of $4.16 from 2021-05-28

1 week (2021-07-25)	N/A
1 month (2021-07-02)	13.66%
3 months (2021-05-05)	18.86%
6 months (2021-02-01)	N/A

1 year (2020-08-01)	N/A
2 years (2019-08-01)	N/A
3 years (2018-08-01)	N/A
5 years (2016-08-01)	N/A

Quotient financials

Revenue TTM	$43.4 million
Gross profit TTM	$23.3 million
Return on assets TTM	-21.63%
Return on equity TTM	-737.71%
Profit margin	-250.05%
Book value	$0.08
Market capitalisation	$345.2 million

TTM: trailing 12 months

Shorting Quotient shares

There are currently 5.1 million Quotient shares held short by investors – that's known as Quotient's "short interest". This figure is 7.8% up from 4.7 million last month.

There are a few different ways that this level of interest in shorting Quotient shares can be evaluated.

Quotient's "short interest ratio" (SIR)

Quotient's "short interest ratio" (SIR) is the quantity of Quotient shares currently shorted divided by the average quantity of Quotient shares traded daily (recently around 516451.87817259). Quotient's SIR currently stands at 9.85. In other words for every 100,000 Quotient shares traded daily on the market, roughly 9850 shares are currently held short.

However Quotient's short interest can also be evaluated against the total number of Quotient shares, or, against the total number of tradable Quotient shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Quotient's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Quotient shares in existence, roughly 50 shares are currently held short) or 0.0714% of the tradable shares (for every 100,000 tradable Quotient shares, roughly 71 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Quotient.

Find out more about how you can short Quotient stock.

Quotient share dividends

We're not expecting Quotient to pay a dividend over the next 12 months.

Quotient share price volatility

Over the last 12 months, Quotient's shares have ranged in value from as little as $2.99 up to $8. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quotient's is 2.2557. This would suggest that Quotient's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Quotient overview

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ COVID-19 Microarray that is designed as a serological disease screening microarray specific to COVID-19 antibody detection. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland. .

Frequently asked questions

What percentage of Quotient is owned by insiders or institutions?
Currently 1.653% of Quotient shares are held by insiders and 91.343% by institutions. How many people work for Quotient?
Latest data suggests 435 work at Quotient. When does the fiscal year end for Quotient?
Quotient's fiscal year ends in March. Where is Quotient based?
Quotient's address is: B1, Business Park Terre Bonne, Eysins, Switzerland, 1262 What is Quotient's ISIN number?
Quotient's international securities identification number is: JE00BLG2ZQ72 What is Quotient's CUSIP number?
Quotient's Committee on Uniform Securities Identification Procedures number is: G73268107